About

Lantheus is a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow^® disease.

SPECT Products

For over 65 years, Lantheus has provided the nuclear medicine market first-in-class diagnostic radiopharmaceutical products including TechneLite^® (Technetium Tc 99m Generator), NEUROLITE^® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection), and Xenon Xe-133 Gas. The launch of the most successful diagnostic radiopharmaceutical in history, Cardiolite^® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), solidified our commitment to healthcare and innovation.